AstraZeneca

AstraZeneca may not stay in the vaccine business in the long run and is looking to buy small and mid-sized companies specialising in oncology and cardiovascular treatments, Chief Executive Pascal Soriot said in a Reuters Newsmaker…

Patient outrage as NHS is blocked from supplying Covid drug to vulnerable patients who are not protected by vaccinesEvusheld can provide protection to patients with diseases such as blood cancerThe drug can help those who do…

More than 100 doctors have written to the Government demanding that the NHS funds a Covid drug that protect vulnerable patients who don’t respond to the vaccines, The Mail on Sunday can reveal.They have been joined by 19 charities to pen a…

Britain must urgently build up stocks of a Covid drug that could be a lifesaver for half a million extremely vulnerable Britons, campaigners say.Evusheld, developed by AstraZeneca, will allow people who were less likely to get an immune…

Canada is about to toss more than half of its doses of the Oxford-AstraZeneca COVID-19 vaccine because it couldn’t find any takers for it either at home or abroad. It also has yet to explain how it plans to manage millions of doses of…

A cancer jab custom-made from patients’ own tumours has produced ‘really hopeful’ results in a trial on NHS patients.None of the eight head and neck cancer sufferers, who had a high chance of relapse, have seen their tumours return four…

Health chiefs are poised to roll out a life-saving Covid drug designed to protect vulnerable patients who don't respond to the vaccine, The Mail on Sunday has learned.Government experts have been assessing the medication and Ministers are…

A drug proven to protect vulnerable patients still at risk from Covid can also radically slash their chances of dying if they do become infected, a study has discovered.Evusheld, developed by AstraZeneca, was approved by UK regulators in…

AstraZeneca's tests for treatment of people at risk of death from coronavirus has revealed good results in a late-stage trial, its maker AstraZeneca announced Wednesday. The British…

One week after his first dose of the AstraZeneca Covid-19 vaccine in March last year, the unthinkable happened to Richard Todman. The 60-year-old part-time employment judge from North London suffered catastrophic blood clots in his bowel.…